New York [US], June 2 (ANI): According to a preclinical study conducted by researchers at Weill Cornell Medicine, genetically engineered immune cells successfully targeted the specific cancer cells that may be responsible for relapse of acute myeloid leukaemia (AML), a type of blood cancer, and proved effective in animal models of the disease.
Washington [US], January 29 (ANI): Two recent discoveries by stem cell scientists at Cedars-Sinai have offered a ray of hope that may help make cancer treatment more efficient and shorten the time taken for people to recover from radiation and chemotherapy. In the first study, published in the journal 'Blood', investigators discovered a protein that is expressed by blood stem cells that could aid in identifying, studying and deploying the cells for treatments.
Washington [US], January 9 (ANI): According to a study from researchers at Weill Cornell Medicine and Cornell's Ithaca campus, aggressive and relatively common lymphomas called diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves.
Washington [US], January 4 (ANI): Aggressive and relatively common lymphomas called diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study from researchers at Weill Cornell Medicine and Cornell's Ithaca campus.
\
\
\
\
\
\
\
\
